NATCO 30 (Lansoprazole delayed-release 30 mg)
Pill imprint NATCO 30 has been identified as Lansoprazole delayed-release 30 mg.
Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; helicobacter pylori infection; aspiration pneumonia (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for NATCO 30 (Lansoprazole delayed-release 30 mg)
More about lansoprazole
- Lansoprazole delayed-release capsules
- Lansoprazole orally disintegrating tablets
- Lansoprazole powder packet
- Lansoprazole (Advanced Reading)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...